Is serum galectin-3 a potential predictor of the response to active specific immunotherapy in melanoma patients?
Vereecken
Pierre
P
Heenen
Michel
M
Babar
Sajida
S
Van Baren
Nicolas
N
D014408:Biomarkers, Tumor / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay; D037502:Galectin 3 / Q000097:blood*; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D008545:Melanoma / Q000097:blood* / Q000628:therapy*; D012878:Skin Neoplasms / Q000097:blood* / Q000628:therapy*; D018709:Statistics, Nonparametric
D014408:Biomarkers, Tumor; D037502:Galectin 3